1
Erythromycin production in the new formulation of bagasse based medium was found to be 512 mg/L which was 28 % higher than glucose based medium
An industrial erythromycin production strain of Saccharopolyspora erythraea spp
Background: S
Industrial microbiology can be used to produce antibiotics via the process of fermentation, where the source microorganism is grown in large containers (100,000–150,000 liters or
EFR is the byproduct of the erythromycin production process; it contains mainly inactive mycelial
Pathogens, such as Escherichia coli (E
The production process of this antibiotic is mainly by means of submerged culture system of either free cells (Martin and Bushell, 1996, Heydarian et al
The cultivation of S
We herein report the development of an industrial erythromycin-producing strain, Sac
The whole process carried out is aerobic and the method involved is fed-batch
Antibiotics are produced on a large scale by cultivating and manipulating fungal cells
However, in the oil-containing media, a higher productivity of erythromycin was obtained (P<0
• Erythroymycin is produced mainly by submerged fermentation
They consist of 12, 14, 16 and 17 numbered lactone rings with 1-3 sugar glycosidically linked with the glycone (lactone ring) and with
chrysogenum) and the feedstock containing desired N-source, C-source, and minerals etc
Erythromycin production in the new formulation of bagasse based medium was found to be 512 mg/L which was 28 % higher than glucose based medium
In the present study, the metabolic fate of propanol in industrial erythromycin-producing strain Saccharopolyspora erythraea E3 was explored via 13 C labeling 5
Erythromycin fermentation residue (EFR) is a byproduct of bio-fermentation process for producing erythromycin, representing both an economic and environmental burden for the pharmaceutical industry
PHASE 1 Initial fermentation phase and there is little production of streptomycin
erythraea) is the major industrial erythromycin-producing strain [2]
EFR is the byproduct of the erythromycin production process; it contains mainly inactive mycelial dregs, fermentation medium, erythromycin, and metabolites